11C-DPA-713 has much greater specific binding to translocator protein 18 kDa (TSPO) in human brain than 11C-(R)-PK11195
11C-DPA-713 has much greater specific binding to translocator protein 18 kDa (TSPO) in human brain than 11C-(R)-PK11195
复制标题
DOI:
10.1177/0271678x17699223
复制
发表时间:
2018-03-01
影响因子:
6.3
通讯作者:
Fujita, Masahiro
中科院分区:
文献类型:
--
作者:
Kobayashi, Masato;Jiang, Teresa;Fujita, Masahiro
Positron emission tomography (PET) radioligands for translocator protein 18 kDa (TSPO) are widely used to measure neuroinflammation, but controversy exists whether second-generation radioligands are superior to the prototypical agent C-11-(R)-PK11195 in human imaging. This study sought to quantitatively measure the "signal to background'' ratio (assessed as binding potential (BPND)) of C-11-(R)-PK11195 compared to one of the most promising second-generation radioligands, C-11-(R)-PK11195 . Healthy subjects had dynamic PET scans and arterial blood measurements of radioligand after injection of either C-11-(R)-PK11195 (16 subjects) or C-11-DPA-713 (22 subjects). To measure the amount of specific binding, a subset of these subjects was scanned after administration of the TSPO blocking drug XBD173 (30-90 mg PO). C-11-(R)-PK11195 showed a significant sensitivity to genotype in brain, whereas C-11-(R)-PK11195did not. Lassen occupancy plot analysis revealed that the specific binding of C-11-DPA-713 was much greater than that of C-11-(R)-PK11195. The BPND in high-affinity binders was about 10-fold higher for C-11-DPA-713 (7.3) than for C-11-(R)-PK11195 (0.75). Although the high specific binding of C-11-DPA-713 suggests it is an ideal ligand to measure TSPO, we also found that its distribution volume increased over time, consistent with the accumulation of radiometabolites in brain.